Literature DB >> 36040501

Functional and surgical outcomes of Aquablation in elderly men.

Brendan L Raizenne1, David Bouhadana2, Kevin C Zorn3, Neil Barber4, Peter Gilling5, Steven Kaplan6, Gopal Badlani7, Bilal Chughtai8, Dean Elterman9, Naeem Bhojani3.   

Abstract

PURPOSE: As benign prostatic hyperplasia (BPH) is an age-related process, growing interest in surgical management for elderly men has emerged. Recently, Aquablation was approved for treatment of BPH associated lower urinary tract symptoms (LUTS) and utilizes robotic ultrasound guided surgeon-controlled waterjet ablation. We assessed the differences in functional and surgical outcomes between elderly and young men undergoing Aquablation for BPH/LUTS.
MATERIALS AND METHODS: We retrospectively assessed prospectively collected data from the WATER I (NCT02505919) and WATER II (NCT03123250) clinical trials reporting safety and efficacy of Aquablation in the treatment of LUTS/BPH in men 45-80 years with a prostate between 30 and 80 cc, and 80 cc and 150 cc, respectively. Men ≥ 65 years were defined as elderly and men < 65 years as young.
RESULTS: Of 217 patients included, 83 (38.2%) were young and 134 (61.8%) were elderly. Mean age (SD) was 59.3 (± 3.4) years and 71.2 (± 4.2) years for young and elderly men, respectively. At 3 years of follow-up compared to baseline, elderly men showed similar reductions in total IPSS (7.68 points vs 7.12 points, p > 0.05) and similar increases in Qmax (20.6 mL/s vs 19.3 mL/s, p > 0.05) compared to young men. The ejaculatory dysfunction rate was similar for both cohorts (12.0% vs 9.7%, p > 0.05). Elderly men experienced similar annual retreatment rates compared to young men (1.5% vs 0.8% p > 0.05).
CONCLUSIONS: Elderly men undergoing Aquablation have similar functional and surgical outcomes as young men. Elderly patient BPH surgical counseling should, therefore, consider Aquablation as a treatment option for LUTS/BPH.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Aquablation; BPH; Elderly; Robotics

Year:  2022        PMID: 36040501     DOI: 10.1007/s00345-022-04137-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   3.661


  5 in total

1.  Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml: preliminary results of a prospective, randomized clinical trial.

Authors:  Hazem Elmansy; Abdulaziz Baazeem; Ahmed Kotb; Hesham Badawy; Essam Riad; Ashraf Emran; Mostafa Elhilali
Journal:  J Urol       Date:  2012-05-15       Impact factor: 7.450

2.  Does age affect the efficacy and safety of GreenLight HPS™ laser photoselective vaporization prostatectomy?

Authors:  Xiao Gu; Kurt Strom; Massimiliano Spaliviero; Carson Wong
Journal:  Aging Male       Date:  2011-11-30       Impact factor: 5.892

Review 3.  Office-Based Procedures for BPH.

Authors:  Bruce Gao; Steven Lu; Naeem Bhojani; Kevin C Zorn; Bilal Chughtai; Dean Elterman
Journal:  Curr Urol Rep       Date:  2021-12-16       Impact factor: 3.092

4.  Age-stratified outcomes of holmium laser enucleation of the prostate.

Authors:  Chinedu O Mmeje; Rafael Nunez-Nateras; Jonathan N Warner; Mitchell R Humphreys
Journal:  BJU Int       Date:  2013-03-19       Impact factor: 5.588

5.  Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial.

Authors:  Peter Gilling; Neil Barber; Mohamed Bidair; Paul Anderson; Mark Sutton; Tev Aho; Eugene Kramolowsky; Andrew Thomas; Barrett Cowan; Ronald P Kaufman; Andrew Trainer; Andrew Arther; Gopal Badlani; Mark Plante; Mihir Desai; Leo Doumanian; Alexis E Te; Mark DeGuenther; Claus Roehrborn
Journal:  Can J Urol       Date:  2020-02       Impact factor: 1.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.